Effect of skin infiltration with ropivacaine on postoperative pain in patients undergoing craniotomy by unknown
Zhou et al. SpringerPlus  (2016) 5:1180 
DOI 10.1186/s40064-016-2856-3
RESEARCH
Effect of skin infiltration with ropivacaine 
on postoperative pain in patients  
undergoing craniotomy
Hongyu Zhou†, Mengchan Ou†, Yaoxin Yang, Qian Ruan, Yan Pan and Yu Li* 
Abstract 
Background: Local anesthetic infiltration has been used to manage postoperative pain in various surgeries. The 
present study was aimed to investigate the effect of skin infiltration with 0.5 % ropivacaine on postoperative pain in 
patients undergoing craniotomy.
Methods: One hundred and six patients with ASA I/II scheduled to undergo elective craniotomy were enrolled dur-
ing March to November in 2015 in this prospective, randomized, placebo-controlled, double-blind study. After the 
anesthesia induction, skin along the incision was infiltrated with 0.5 % ropicavaine (group R, n = 53) or 0.9 % normal 
saline (group C, n = 53), respectively. Morphine was used as rescue analgesic postoperatively. Morphine consumption 
during the first 24 postoperative hours was recorded as the primary outcome, and the time to first rescue require-
ment was also recorded. Pain was assessed at 2, 4, 8, 24 h, 7 days, 3 months after surgery by visual analog scale (VAS). 
Heart rate and mean arterial pressure were recorded before anesthesia induction (T1), after anesthesia induction (T2), 
after scalp infiltration (T3), during skull drilling (T4), mater cutting (T5) and skin closure (T6).
Results: Morphine consumption during the first 24 postoperative hours was significantly higher in group C than in 
group R (13.36 [6.5, 20] vs. 6.3 [0, 10] mg, P < 0.05). The first time of patients needed rescue analgesic was prolonged 
in group R as compared with group C (6.16 [3.4, 8.0] vs. 3.87 [2.3, 4] h, P < 0.05). Postoperative VAS and hemodynamic 
signs during the first 24 h showed no significant difference in two groups. The incidence of persistent pain on 7 days 
and 3 months postoperatively had no significant differences between two groups. Besides one patient (2 %) endur-
ing moderate pain (VAS 4–7) in group C, the number of patients suffering from mild pain (VAS 1–3) was 17 (33.3 %) in 
group R and 17 (34 %) in group C 3 months after surgery.
Conclusion: The results suggest 0.5 % ropivacaine scalp infiltration before skin incision has favorable analgesic effect 
in reducing morphine consumption and prolong the time of first rescue analgesic requirement after surgery.
Trial registration Chinese Clinical Trial Registry (http://www.chictr.org.cn/) registration number: ChiCTR-IPR-14005717
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Background
Pain following craniotomy has been neglected for dec-
ades because of the presumed absence of nociceptors in 
the brain parenchyma, and innervation virtually limited 
to the meninges, pericranial muscles and fascia (De Ben-
edittis et  al. 1996). In recent studies, patients following 
craniotomy revealed that they experience more than 
minimal pain. Mordhorst et  al. (2010) reported that up 
to 55 % of patients had moderate or severe postoperative 
pain in the first 24 h after undergoing a craniotomy. The 
incidence of chronic pain lasting more than 3  months 
post-craniotomy was 28.4  % postoperatively. Addition-
ally, 14.2  % of the patients reported slight chronic pain 
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and 18.5  % reported that their daily lives were heavily 
affected by pain (Ryzenman et al. 2005).
The significant pain resulting from scalp incision is 
a strong nociceptive stimulus that can provoke abrupt 
changes in sympathetic activity and haemodynamics 
(Hillman et  al. 1987). Acute hypertension is deleterious 
for neurosurgical patients because it may translate into 
increasing intracranial pressure and increased risk of cer-
ebral aneurysm rupture. This effect can result in haem-
orrhage, cerebral hernia or pulmonary oedema (Basali 
et al. 2000), all of which are fatal complications. Research 
has shown that sufficient analgesia can prevent common 
postoperative side effects, enhance patient comfort and 
facilitate the recovery process (Lux et  al. 2011; Taylor 
et al. 2013). Therefore, effective perioperative pain man-
agement is highly demanded to prevent the acute hyper-
tension-related morbidity in neurosurgical patients.
Local anaesthetic infiltration of the scalp has been pro-
posed to lessen intraoperative haemodynamic responses 
to craniotomy (Bloomfield et  al. 1998). However, the 
efficacy of local anaesthetic wound infiltration for the 
treatment of acute pain after neurosurgery is contro-
versial (Song et  al. 2015; Law-Koune et  al. 2005) prob-
ably because of the heterogeneity of studies. Further, 
according to previous studies (Bisgaard et  al. 2005), the 
intensity of acute pain postoperatively may be associ-
ated with a high incidence of chronic pain. Despite the 
aforementioned high prevalence of chronic pain post-
craniotomy (Mordhorst et  al. 2010), no authoritative 
therapeutic guidelines on chronic post-craniotomy head-
ache are available. This makes pain management par-
ticularly difficult. Therefore, the aim of this prospective, 
randomised study was to explore the hypothesis that the 
preemptive skin infiltration with 0.5  % ropivacaine in 
patients undergoing craniotomy is effective for postop-
erative acute pain management and might contribute to 
reducing the incidence of chronic pain.
Methods
The Ethical Committee at our institution approved this 
prospective, randomised, double-blinded study. Ethical 
approval for this study (Ethical Committee No. 213) was 
provided by the Ethical Committee of West China Hospi-
tal, Sichuan, China (Prof Li) on 10 December 2014. The 
written informed consent was obtained from all patients 
preoperatively. We also registered the study protocol in 
the Chinese Clinical Trial Registry (registration number: 
ChiCTR-IPR-14005717). One hundred and fifty-four 
patients aged between 18 and 70  years with American 
Society of Anesthesiologists (ASA) physical status I/II 
who were scheduled for elective craniotomy under gen-
eral anaesthesia were recruited in this study.
The exclusion criteria included inability to under-
stand and use the visual analogue scale (VAS), patients 
undergoing intervertebral anaesthesia and/or epidural 
analgesia, patients managed with postoperative patient-
controlled epidural analgesia or postoperative intra-
venous analgesia, inability to communicate because of 
impaired consciousness (Glasgow Coma Score less than 
15), proven or suspected allergy to local anaesthetics, a 
previous scalp incision, and patients treated with opioids 
for more than 14 days in the last 3 months or nonopioid 
analgesics at a frequency greater than 5 times per week.
The day before the surgery, all enrolled patients 
received explanations as to the usage of a 10-cm VAS 
(0  =  no pain, 10  =  the worst pain) by the investiga-
tor. No premedication was administered preoperatively. 
The randomised group assignment was performed with 
a computer-generated random number table. The ran-
domisation information was concealed by using opaque 
envelopes. In the ward, after undergoing a preoperative 
interview, patients considered eligible received a unique 
random code and were randomly assigned into either the 
ropivacaine group (group R) or the placebo group (group 
C). On the day of surgery, according to the random code 
of the patient, an anaesthetic nurse prepared the solution 
of normal saline or ropivacaine. All solutions were pre-
pared in identical syringes. The random code, patient’s 
information and group name were enclosed in the sealed 
opaque envelope. The anaesthetists who performed the 
anaesthesia and recorded the intraoperative data, the 
neurosurgeons who performed the scalp infiltration, and 
patients were all blinded to the group assignment. The 
envelope was opened only if emergency unblinding was 
required. All the follow-up procedures were conducted 
by another nurse who was also blind to the treatment 
group assignment.
The electrocardiogram, noninvasive blood pres-
sure and pulse oximetry were monitored continuously. 
Anaesthesia was induced with sufentanil 0.2–0.3  µg/
kg, midazolam 0.05  mg/kg, and propofol 2  mg/kg. Tra-
cheal intubation was facilitated by rocuronium 0.7  mg/
kg. After the induction of general anaesthesia, the radial 
artery was cannulated and connected to a transducer 
placed at the midaxillary level. Propofol (4–12  mg/
kg/h), remifentanil (0.1–0.2  mg/kg/min) and 1.0 mini-
mum alveolar concentration of sevoflurane mixed with 
oxygen (50 %) and air (50 %) were used for maintenance 
of anaesthesia and adjusted to maintain the mean arte-
rial pressure (MAP) within 60 and 80 mmHg. Ventilation 
was mechanically controlled to achieve an end-tidal CO2 
(ETCO2) of 30–35 mmHg.
The neurosurgeon infiltrated the scalp along the inci-
sion site 5  min before the surgery. Group R received 
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10  ml of 0.5  % ropivacaine while group C received an 
equal volume of 0.9 % normal saline solution.
Heart rate (HR) and blood pressure (BP) were meas-
ured before anaesthesia induction (T1, baseline value), 
after anaesthesia induction (T2), after scalp infiltration 
(T3), during skull drilling (T4), dura mater cutting (T5) 
and skin closure (T6). The total consumption of sufenta-
nil and remifentanil during the operation were recorded. 
The BP and HR were maintained within the 20  % from 
the preoperative baseline value through the surgery via 
adjusting the anaesthetic dosage or administration of 
vasoactive agents such as nicardipine.
Postoperative VAS scores, postoperative nausea and 
vomiting (PONV) scores, sedation scores, HR and BP 
were recorded at 2, 4, 8, and 24 h postoperatively. Mor-
phine was used as rescue analgesic during the first 24 h 
postoperatively. If the measured VAS was >4 or patients 
requested analgesia, the rescue analgesia was adminis-
tered by a nurse as an intravenous injection of morphine 
5 mg. Intravenous morphine 2.5 mg was given repeatedly 
at a minimal interval of 10 min if needed until VAS was 
<4.
The primary outcome of this study was morphine con-
sumption during the first 24 h postoperatively. The con-
sumed dosage of morphine and the time to first rescue 
requirement were recorded carefully. The patients’ satis-
faction with postoperative analgesia was recorded at 24 
and 48 h postoperatively. The VAS at 7 days and 3 months 
postoperatively were assessed. Patients whose VAS was 
≥1 at 3  months postoperatively were diagnosed with 
chronic postoperative pain. Adverse events (AEs) and 
serious adverse events (SAEs) were recorded throughout 
the study period. An AE was defined as any untoward 
medical occurrence. An SAE included death, immedi-
ately life-threatening conditions, coma, in-patient hospi-
talisation or prolongation of existing hospitalisation.
Statistical analysis
All statistical analyses were performed with IBM SPSS 
statistics 17.0 software (IBM Corporation, Armonk, New 
York). Normally distributed continuous variables were 
present as means ± stand deviation, and Student’s t test 
was used to determine the significance of the difference 
between the two independent groups. Repeated meas-
ured continuous variables were analysed with repeated-
measures analysis of variance to detect differences. 
Non-normally distributed continuous variables were pre-
sented as median (quartile range) and were analysed with 
Mann–Whitney U test or Kruskal–Wallis test. Dichoto-
mous variables were analysed with Chi square tests. Dif-
ference was considered statistically significant when the 
P value was <0.05.
Results
One hundred and fifty-four patients were enrolled. Of 
these, the surgeries of seven patients were cancelled 
after randomisation, 13 patients were admitted to ICU 
for ventilation, 16 patients were aphasic or were incapa-
ble of communicating, and 12 patients used other anal-
gesics rather than morphine for postoperative analgesia. 
Thus, 106 patients were analysed (53 in group R and 53 
in group C). No patient was lost to follow-up during the 
first 7 days postoperatively. Results for 3 months postop-
eratively are reported for 50 patients in group C and 51 
in group R because five additional patients were excluded 
from the study (Fig. 1): three patients died (1 patient in 
group R, 2 patients in group C) and two patients were 
lost to follow-up (1 patient in each group). There were 
no significant differences with respect to patient charac-
teristics and duration of surgery between the two groups 
(Table 1).
Morphine consumption during the first 24 postop-
erative hours was significantly higher in group C than in 
group R (13.36 [6.5, 20] vs. 6.3 [0, 10] mg, P < 0.05; Fig. 2). 
The first time patients requested rescue analgesia was 
prolonged in group R as compared with group C (6.16 
[3.4, 8.0] vs. 3.87 [2.3, 4] h, P  <  0.05; Fig.  3). The con-
sumed dosage of sufentanil and remifentanil during the 
surgery was lower in group R than in group C, but the 
difference was not significant (P > 0.05; Fig. 4).
The assessment of postoperative VAS at several time 
points during the first 24 h postoperatively did not reveal 
Fig. 1 Flow of patients through testing and follow-up
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any significant differences between groups. The incidence 
of pain was 77.4 % in group R and 79.2 % in group C at the 
first 2 h postoperatively. Six (11.3 %) patients suffered from 
moderate or severe pain in group R and 11 (20.7  %) in 
group C at the 2 h postoperatively, but the difference was 
not significant (P  >  0.05; Fig.  5). The prevalence of post-
operative pain at 7 days postoperatively and the incidence 
of chronic postoperative pain at 3 months were not signifi-
cantly different between groups (Table 2). Aside from one 
patient (2 %) who presented moderate pain in group C, 17 
(33.3 %) patients in group R and 17 (34 %) in group C pre-
sented mild pain at 3 months postoperatively (Table 3).
There were no significant differences between groups 
for HR and MAP at each intraoperative time point, 
except for T3 and T4. At the time points of T3 and T4, 
the HR and MAP in group C were significantly higher 
than in group R. There were significant differences in HR 
and MAP before and after the skin incision as shown by 
within group analysis. However, the changes in HR and 
MAP between the time points, T2 and T3, were signifi-
cantly lower in group R than that in group C (P < 0.05; 
Fig.  6). The HR and MAP at every postoperative time 
point were not significantly different between groups 
(Fig. 7).
In both groups, the postoperative Ramsay scores were 
not significantly different at any time point (P  >  0.05; 
Fig.  8). The incidence of PONV at each time point, 
except for the first 8  h postoperatively (10 vs. 3), was 
not significantly different between groups (Table  4). No 
patient experienced respiratory depression (defined as a 
Table 1 The characteristic of  patients undergoing crani-
otomy (n = 106)
Group R (n = 53) Group C (n = 53) P values
Age (year) 48.26 ± 11.99 49.00 ± 13.28 0.765
Sex
 Female 23 26 0.559
 Male 30 27
BMI (kg/m2) 22.08 ± 2.36 21.51 ± 2.01 0.187
ASA
 I 9 8 0.791
 II 44 45
Fig. 2 Comparison of morphine consumption during the first 24 
postoperative hours. Group C control group, Group R ropivacaine 
group. *P < 0.05 versus control group
Fig. 3 Comparison of the first time patients requested rescue anal-
gesia. Group C control group, Group R ropivacaine group. *P < 0.05 
versus control group
Fig. 4 Comparison of sufentanil and remifentanil consumptions dur-
ing the surgery. Group C control group, Group R ropivacaine group
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respiratory rate <10 breaths per minute or SpO2 < 90 %). 
The length of hospital stay was not significantly different 
between groups.
Discussion
This prospective, randomised, double-blinded, placebo-
controlled study showed that the scalp infiltration per-
formed preoperatively with 0.5 % ropivacaine decreased 
the morphine consumption for rescue analgesia within 
24 h postoperatively as well as the incidence of PONV at 
8 h. However, this intervention had no effect on chronic 
postoperative pain at 3  months, and did not increase 
the incidence of postoperative AEs. In terms of optimal 
postoperative pain management regimen, in the present 
study, VAS scores at different time points were not signif-
icantly different between groups. However, the reduced 
morphine consumption during the first 24  h postop-
eratively and the prolonged time of first rescue analgesic 
requirement were evidence of the beneficial effect of the 
ropivacaine scalp infiltration for pain management in 
craniotomy patients.
Fig. 5 Comparison of VAS scores in both the groups after surgery. 
Group C control group, Group R ropivacaine group
Table 2 Prevalence of  pain at  1  week after  surgery 
and 3 months after surgery
1 week after surgery 3 months after surgery
Group C 27/53 18/50
Group R 26/53 17/51
Table 3 The intensity of pain in 3 months postoperatively 
assessed by VAS
No pain = 0, mild pain = 1–3, moderate pain = 4–7, severe pain = 8–10
No pain Mild pain Moderate pain
Group C 34/51 17/51 0
Group R 32/50 17/50 1/50
Fig. 6 Comparison of HR and MAP changes during surgery. T1 before 
anaesthesia induction, T2 after anaesthesia induction, T3 after scalp 
infiltration, T4 during skull drilling, T5 dura mater cutting, T6 skin 
closure. Group C control group, Group R ropivacaine group
Fig. 7 Comparison of HR and MAP changes after surgery. Group C 
control group, Group R ropivacaine group
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Ropivacaine, the local anaesthetic used in our study, 
has a biphasic vascular effect. It is reported that 0.5  % 
ropivacaine can contract the blood vessels, which is the 
main function of epinephrine (Hansen 2004). Epineph-
rine was not used in our study because of the haemo-
dynamic changes it causes, especially in patients with 
aneurysms (Yang et al. 2007).
Considering the serious complications caused by 
headaches postoperatively, it is important to select an 
effective analgesic to alleviate postoperative pain. No 
ideal analgesic has been described for use in patients 
undergoing craniotomy. Despite the lack of clinical evi-
dence related to craniotomy, nonopioid analgesics such 
as nonsteroidal anti-inflammatory drugs, and opioids 
are widely used to relieve postoperative pain (Gottschalk 
and Yaster 2009; Molnar et al. 2014). Opioid analgesics 
are the main intervention for pain control in patients. 
Moore et  al. (2015) reported that dexketoprofen tro-
metamol 25  mg combined with tramadol hydrochlo-
ride 75  mg had favorable analgesic effect on moderate 
to severe pain. Morphine has been found to be the most 
effective analgesic among these agents, it is the gold 
standard of moderate and severe pain management 
(Gottschalk and Yaster 2009).
Retrospective and prospective studies provide con-
flicting results regarding scalp infiltration with local 
anaesthesia, such as diverse changes of perioperative 
haemodynamics, VAS scores, and morphine consump-
tion. Pre-incision scalp infiltration was studied by Biswas 
and Bithal (2003): they concluded that the scalp infil-
tration may delay the requirement of the first analgesic 
dose. They assumed that in the bupivacaine group, the 
duration of skin hypoesthesia produced by 0.25 % bupi-
vacaine (Swerdlow and Jones 1970) was longer than the 
duration of surgery time, which contributed to the appar-
ently delayed requirement of the first analgesic dose. In 
our study, the time to first rescue analgesic requirement 
was prolonged in group R compared with group C. How-
ever, we found that despite the similarity of postoperative 
VAS scores in groups R and C, morphine consumption 
during the first 24 postoperative hours was significantly 
higher in group C than in group R. Additionally, in some 
cases, morphine was used before the time points of VAS 
assessment, which may have caused discordance between 
morphine consumption and the VAS scores obtained.
In contrast, Law-Koune et al. (2005) assessed the ben-
efit of scalp infiltration on acute postoperative pain and 
found that there was a transient effect with ropivacaine 
or bupivacaine, which lasted only 1 or 2  h. Batoz et  al. 
(2009) considered that the small sample size and the dif-
ficulty of obtaining a reliable pain evaluation by VAS may 
also be accountable for ineffective analgesia. Further-
more, pain was referred to as predominantly superficial 
in 86  % of the patients, suggesting somatic rather than 
visceral origin and possibly mainly involving pericranial 
muscles and soft tissues (De Benedittis et al. 1996). Nev-
ertheless, in our study, we only infiltrated the subcuta-
neous tissue at the site of the scalp incision, which may 
result in unsatisfactory analgesia.
Opioids can increase the prevalence of nausea and 
vomiting. In our study, the incidence of PONV in group 
R was significantly reduced at 8 h compared with group 
C. It is reported that postoperative pain and the opioids 
used are associated with PONV (Kenny 1994). PONV 
can cause tension on the suture lines, hypertension, 
increased bleeding under skin flaps, among other com-
plications (Camu et al. 1992). Therefore, we consider that 
the reduction of opioid consumption in the present study 
contributed to fewer opioid-related AEs.
As far as we know, only a few studies evaluated chronic 
postoperative headache. In particular, whether chronic 
pain can be relieved by pre-incisional scalp infiltration 
with local anaesthetics has been assessed rarely. In our 
study, chronic pain assessed by VAS at 3 months postop-
eratively was not significantly different between groups. 
Multiple reasons may account for this phenomenon. 
Fig. 8 Comparison of postoperative Ramsay scores in both the 
groups after surgery. Group C control group, Group R ropivacaine 
group
Table 4 Incidence of postoperative nausea and vomiting
* P < 0.05 versus group C
2 h 4 h 8 h 24 h
Group C 6/53 5/53 10/53 10/53
Group R 5/53 5/53 3/53* 10/53
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First, as related studies indicated, acute pain can pro-
gress to chronic pain. The origin of most acute pain is the 
locally damaged tissue and inflammatory response (Kauf-
man et al. 2005). It is the development of peripheral and 
central sensitisation—the plasticity of the nervous sys-
tem after an injury—that leads to a reduced pain thresh-
old, amplification of pain response, and spread of pain 
to non-injured areas (Katz et  al. 2003; Mifflin and Kerr 
2014). Neil and Bannister (2015) summarised the risk 
factors associated with the development of chronic pain 
postoperatively as being indicative of either peripheral 
or central neural sensitisation, neural trauma or adverse 
psychology. Considering this and the similar VAS scores 
within 7 days postoperatively, acute pain may result in a 
similar incidence and intensity as chronic pain. Second, 
depression and anxiety among patients that undergo 
neurosurgery are conditions associated with the devel-
opment of chronic headache. The intensity of depression 
and anxiety has a positive correlation with the frequency 
of post-craniotomy headache (Rocha et  al. 2008). Last, 
since the post-craniotomy headache involves the menin-
ges, pericranial muscles and soft tissues, it is unlikely 
that scalp infiltration can prevent the onset of chronic 
headache.
According to previous research, the incidence and 
intensity of postoperative headache tends to decrease 
with the passage of time (Rocha-Filho 2015). Despite 
the low incidence of the chronic post-craniotomy pain, 
which tends to decrease with time, everyday life can be 
negatively influenced by such pain because of its long-
lasting nature. As reported previously, neuropathic pain 
is probably the most common type of persistent post-
surgical pain (Kehlet et  al. 2006). Allodynia, hyperalge-
sia, and sensitisation have been reported in proximity to 
the surgical incision site several months postoperatively 
(Mosek et al. 1999). The neurons, glia, and immune cells 
all play a role in the development of chronic pain (Mifflin 
and Kerr 2014). The risk factors, for example, genetic 
susceptibility, preceding pain, psychosocial factors, bac-
terial infection, hypersensitivity, age, and sex, may con-
tribute to persistent postoperative pain in unique ways 
(Kehlet et  al. 2006). Preemptive, preventive, and multi-
modal analgesia are currently being practiced during the 
operative procedures, but whether they produce a clini-
cally meaningful reduction in the intensity or duration of 
chronic pain remains unclear.
There are several limitations to our study. Given the 
limitations of VAS, we combined VAS and morphine 
consumption to assess postoperative pain to better 
reflect the effects of analgesia. As reported previously, 
questionnaires such as the Brief Pain Inventory and 
quantitative sensory testing (QST) have been validated 
for the assessment of chronic pain (Wilder-Smith et  al. 
2003). Neuroplasticity quantified by QST may be a sig-
nificant factor in determining acute and perhaps chronic 
pain outcomes postoperatively (Woolf and Salter 2000). 
Furthermore, we may pay attention to neuropathic pain 
which affect the life of patients in future research.
The preoperative scalp infiltration with 0.5  % ropi-
vacaine in patients undergoing craniotomy lessened 
the haemodynamic responses during scalp incision. 
Although there was no advantage of the scalp infiltra-
tion with 0.5 % ropivacaine in postoperative VAS, acute 
or chronic pain over placebo, the infiltration with ropi-
vacaine did decrease morphine consumption during the 
first 24 h postoperatively and prolonged the time to first 
rescue analgesic requirement postoperatively.
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